Recent Finacing
Recent Raise
Cyto-Facto is a CMO/CDMO providing process development and commercial manufacturing for gene and cell therapies including CAR‑T, using automated, digitized manufacturing platforms like CytoFactory 4.0 to improve productivity and accuracy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors